Cargando…

Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome

OBJECTIVES: Cytosolic DNA-sensing pathway stimulation prompts type I IFN (IFN-I) production, but its role in systemic IFN-I pathway activation in primary SS (pSS) is poorly studied. Here we investigate the responsiveness of pSS monocytes and plasmacytoid dendritic cells (pDCs) to stimulator of inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huijser, Erika, Bodewes, Iris L A, Lourens, Mirthe S, van Helden-Meeuwsen, Cornelia G, van den Bosch, Thierry P P, Grashof, Dwin G B, van de Werken, Harmen J G, Lopes, Ana P, van Roon, Joel A G, van Daele, Paul L A, Brkic, Zana, Dik, Willem A, Versnel, Marjan A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348764/ https://www.ncbi.nlm.nih.gov/pubmed/35022662 http://dx.doi.org/10.1093/rheumatology/keac016

Ejemplares similares

Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype
por: Huijser, Erika, et al.
Publicado: (2022)

Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome
por: Huijser, Erika, et al.
Publicado: (2021)

Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics
por: Kolijn, P. Martijn, et al.
Publicado: (2023)

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
por: Maria, Naomi I, et al.
Publicado: (2014)

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
por: Brkic, Zana, et al.
Publicado: (2013)

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets
por: Bodewes, Iris L. A., et al.
Publicado: (2019)

Distal renal tubular acidosis in primary Sjögren syndrome
por: Both, Tim, et al.
Publicado: (2012)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

P318: LOSS OF SCARNA12 RESULTS IN ABERRANT SPLICING OF TARGET GENES AND DOWNREGULATION OF P53 IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL)
por: Verbeek, Martijn, et al.
Publicado: (2023)

Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland
por: Wildenberg, Manon E, et al.
Publicado: (2008)

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
por: Wahadat, M. Javad, et al.
Publicado: (2018)

Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
por: Wahadat, M Javad, et al.
Publicado: (2022)

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
por: Hamkour, Safae, et al.
Publicado: (2023)

Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assays
por: Vergouwen, Daphne P. C., et al.
Publicado: (2023)

Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK
por: Li, Ling, et al.
Publicado: (2023)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition
por: Zhao, Manzhi, et al.
Publicado: (2023)

Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
por: Huijser, Erika, et al.
Publicado: (2021)

Blood myxovirus resistance protein‐1 measurement in the diagnostic work‐up of suspected COVID‐19 infection in the emergency department
por: Tong‐Minh, Kirby, et al.
Publicado: (2022)

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
por: Flessa, Christina-Maria, et al.
Publicado: (2022)

The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis
por: Welzen-Coppens, Jojanneke M. C., et al.
Publicado: (2013)

The Gene Expression Profile of CD11c(+)CD8α(−) Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse
por: Beumer, Wouter, et al.
Publicado: (2014)

ProteoDisco: a flexible R approach to generate customized protein databases for extended search space of novel and variant proteins in proteogenomic studies
por: van de Geer, Wesley S, et al.
Publicado: (2021)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply
por: Brkic, Zana, et al.
Publicado: (2014)

Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus
por: Rietveld, Anke, et al.
Publicado: (2018)

FASTAFS: file system virtualisation of random access compressed FASTA files
por: Hoogstrate, Youri, et al.
Publicado: (2021)

Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis
por: Both, Tim, et al.
Publicado: (2016)

Katdetectr: an R/bioconductor package utilizing unsupervised changepoint analysis for robust kataegis detection
por: Hazelaar, Daan M, et al.
Publicado: (2023)

A non-lethal method for studying scorpion venom gland transcriptomes, with a review of potentially suitable taxa to which it can be applied
por: Vonk, Freek J., et al.
Publicado: (2021)

Requirements for Carnitine Shuttle-Mediated Translocation of Mitochondrial Acetyl Moieties to the Yeast Cytosol
por: van Rossum, Harmen M., et al.
Publicado: (2016)

Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis: implications for diagnosis
por: Schrijver, Benjamin, et al.
Publicado: (2020)

Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
por: Both, Tim, et al.
Publicado: (2017)

Transcriptome annotation and characterization of novel toxins in six scorpion species
por: Grashof, Dwin G. B., et al.
Publicado: (2019)

Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department
por: Guchelaar, Niels A.D., et al.
Publicado: (2021)

Peripheral blood mononuclear cell hyperresponsiveness in patients with premature myocardial infarction without traditional risk factors
por: Mol, Jan-Quinten, et al.
Publicado: (2023)

Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study
por: Wahadat, Mohamed Javad, et al.
Publicado: (2023)

Somatostatin receptor scintigraphy in sarcoidosis
por: Kamphuis, Lieke SJ, et al.
Publicado: (2011)

Factors associated with hyperresponsiveness to adenosine 5’‐monophosphate in healthy subjects
por: Cox, Claire Alette, et al.
Publicado: (2019)

Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning
por: Mueller, Yvonne M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q5uqjmnkmcnmnpr66av2r60dr8